It’s the third COVID-19 vaccine after the two-shot regimens of Pfizer/BioNTech and
to obtain backing from the WHO, and the primary to be completed in a single injection.
The itemizing covers use in all international locations and for roll-out of the vaccine platform COVAX and comes on the again of European Medicines Company (EMA) authorisation introduced on Thursday.
“Each new, secure and efficient device towards COVID-19 is one other step nearer to controlling the pandemic,” WHO Director-Common Tedros Adhanom Ghebreyesus mentioned in an announcement.
“However the hope supplied by these instruments is not going to materialise except they’re made out there to all folks in all international locations.”
The WHO additionally welcomed the one-shot administration as facilitating vaccination logistics.
J&J’s chief scientist Paul Stoffels instructed Reuters on Thursday the corporate expects to supply as much as 3 billion doses of the vaccine subsequent 12 months, after beforehand pledging to ship 1 billion globally by the tip of 2021.
The WHO mentioned that, beneath an emergency-use itemizing, corporations need to decide to generate additional security and efficacy knowledge to allow full licensing.